Announcements

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

We are proud to have another publication in WM: “Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study” (Journal of Clinical Oncology, 21/7/2023)

Also the ASPEN (BGB-3111-302) Final Analysis Manuscript titled, “Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study” is now published online in the Journal of Clincial Oncology (JCO)

Meletios A. Dimopoulos
Rector of NKUA

Abstract

The phase III ASPEN study demonstrated the comparable efficacy and improved safety of zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia (WM). Here, we report long-term follow-up outcomes from ASPEN. The primary end point was the sum of very good partial response (VGPR) + complete response (CR) rates; secondary and exploratory end points were also reported. Cohort 1 comprised 201 patients (myeloid differentiation primary response 88–mutant WM: 102 receiving zanubrutinib; 99 receiving ibrutinib); cohort 2 comprised 28 patients (myeloid differentiation primary response 88 wild-type WM: 28 zanubrutinib; 26 efficacy evaluable). At 44.4-month median follow-up, VGPR + CR rates were 36.3% with zanubrutinib versus 25.3% with ibrutinib in cohort 1 and 30.8% with one CR in cohort 2. In patients with CXC motif chemokine receptor 4 mutation, VGPR + CR rates were 21.2% with zanubrutinib versus 10.0% with ibrutinib (cohort 1). Median progression-free survival and overall survival were not reached. Any-grade adverse events (AEs) of diarrhea (34.7% v 22.8%), muscle spasms (28.6% v 11.9%), hypertension (25.5% v 14.9%), atrial fibrillation/flutter (23.5% v 7.9%), and pneumonia (18.4% v 5.0%) were more common with ibrutinib versus zanubrutinib; neutropenia (20.4% v 34.7%) was less common with ibrutinib versus zanubrutinib (cohort 1). Zanubrutinib was associated with lower risk of AE-related treatment discontinuation. Overall, these findings confirm the long-term response quality and tolerability associated with zanubrutinib.

Link of publication: https://ascopubs.org/doi/abs/10.1200/JCO.22.02830

Also attached below is the pdf version of the article:

Graduate Studies Scholarship Opportunity | Info Session

Graduate Studies Scholarship Opportunity | Info Session

In May 2024, Georgetown University-The Earth Commons Institute launched its first summer course in Greece. Did you know, however, that Fulbright Greece since 2022, has offered a unique opportunity to a Greek graduate student for a double scholarship to study at Georgetown University | The Earth Commons—Georgetown’s Institute for Environment & Sustainability? Candidates can select from […]

The National and Kapodistrian University of Athens Officially Opens the New ‘Athina I. Martinou’ University Oncology Centre at Attikon General University Hospital – A Landmark Facility for Academic Medicine and Public Health

The National and Kapodistrian University of Athens Officially Opens the New ‘Athina I. Martinou’ University Oncology Centre at Attikon General University Hospital – A Landmark Facility for Academic Medicine and Public Health

The new ‘Athina I. Martinou’ University Oncology Centre was officially opened at Attikon General University Hospital. The facility is part of the 2nd Clinical Department of Propaedeutic Internal Medicine of the National and Kapodistrian University of Athens. It was created thanks to the generous donation of Athanasios Martinos and Marina Martinou, who fully funded the […]

University of Athens Participates in International Commission on Mathematical Instruction through Professor Chronis Kynigos

University of Athens Participates in International Commission on Mathematical Instruction through Professor Chronis Kynigos

The National and Kapodistrian University of Athens is actively involved in the International Commission on Mathematical Instruction (ICMI), with Professor Chronis Kynigos serving as Greece’s national representative. ICMI was established in 1908 at the Fourth International Congress of Mathematicians in Rome (see ICMI History) with the initial mandate of analyzing the similarities and differences in […]

Boston University President Visits the University of Athens: A 151-Year Legacy of Collaboration

Boston University President Visits the University of Athens: A 151-Year Legacy of Collaboration

Melissa Gilliam, President of Boston University, visited the National and Kapodistrian University of Athens, where she was warmly received by the Rector, Professor Gerasimos Siasos. Accompanying President Gilliam were Gloria Waters, Provost and Chief Academic Officer; Tuoyang Mu, Director of International Advancement; and Katerina Lykiardopoulos, member of Boston University’s International Advisory Board. From the University […]

The Department of Pharmacy’s English-Taught Programme Is Now a Reality!

The Department of Pharmacy’s English-Taught Programme Is Now a Reality!

2 October 2025 marked a milestone for the Department of Pharmacy at the National and Kapodistrian University of Athens: the MPharm has officially launched! It was the first day of classes for the Integrated Master’s in Pharmacy, and the new intake of students stepped into the University’s lecture halls! People from five countries abroad started […]

University of Athens—Cyprus Branch Achieves Full Compliance

University of Athens—Cyprus Branch Achieves Full Compliance

The accreditation process for the Cyprus Branch of the National and Kapodistrian University of Athens has now been fully completed. In its initial phase, the Branch will comprise 4 Schools and 8 Departments, located in two cities: Nicosia and Larnaca. More specifically, the Schools and Departments are as follows: i) School of Health Sciences (Nicosia): […]

Professor Gerassimos D. Pagratis to Deliver Lecture at Princeton University

Professor Gerassimos D. Pagratis to Deliver Lecture at Princeton University

Professor Gerassimos D. Pagratis from the Department of Italian Language and Literature at the National and Kapodistrian University of Athens will be giving a lecture at Princeton University on Friday, 3 October 2025, at 12:30 p.m. (Eastern Time, US), titled ‘The Septinsular Republic (1800–1807): International Relations, Consular Network, and Diplomacy’. https://hellenic.princeton.edu/events/2025/workshop-gerassimos-d-pagratis-septinsular-republic-1800-1807-international-relations

University of Athens

The National and Kapodistrian University of Athens, which was inaugurated on May 3, 1837, was initially housed in a renovated Ottoman building on the northeastern side of the Acropolis. This building has since been restored and now functions as the University Museum. Originally named the "Othonian University," after Otto, the first king of Greece, it consisted of four academic departments and 52 students. As the first university of the newly established Greek state, as well as of the broader Balkan and Mediterranean region, it assumed an important socio-historical role, which was pivotal in the development of specific forms of knowledge and culture within the country.

Stay Connected

Follow hub.uoa.gr on Social Media

closebutton
Skip to content